Noel Donnelly

Non-Executive Director / Radiopharm Theranostics

Mr Donnelly brings over 25 years of leadership experience in finance, strategy, and operations within the biopharmaceutical and biotechnology industries. He has a track record of building and leading cross-functional teams, driving corporate governance, and executing complex financial strategies that support rapid company growth. Currently serving as Chief Financial Officer at PepGen Inc. Before joining PepGen, Mr Donnelly was CFO at EIP Pharma (now CervoMed. His career also includes a 15-year tenure at Takeda/Shire PLC, where he held various senior roles, including Vice President of R&D Business Operations. In addition to his operational expertise, Mr Donnelly is experienced in business partnering, valuation, investor relations, and decision support analysis, making him a trusted advisor to both executive leadership teams and boards of directors.

Lists and Charts

Roles

2024

Non-Executive Director

Radiopharm Theranostics

Year started and most recent title

Total Shareholder Return as at 02/12/24

Rank	Company	1 Yr	5 Yr
1630^th	Beam Communications Holdings	-61.55%	-23.17%
1631^st	Leeuwin Metals	-61.59%	0%
1632^nd	Radiopharm Theranostics	-61.68%	0%
1633^rd	Novatti Group	-61.9%	-31.99%
1634^th	Andromeda Metals	-61.93%	-29.84%

View Full List

1767 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®

Person Activity

NEW ROLE: Non-Executive Director, Radiopharm Theranostics

07 Oct 2024

Related Information

Access to our data for Noel Donnelly is only available to paid subscribers with Data & Insights access.

Data & Insights is Western Australia's most accurate and comprehensive business listings and searchable database.

Noel Donnelly is linked to 1 organisation which is included in 1 list - Public Companies - non WA.

To see the data you will need to Subscribe.